Detalhe da pesquisa
1.
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
N Engl J Med
; 373(23): 2237-46, 2015 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26624850
2.
Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.
AIDS Res Ther
; 13: 17, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27042193
3.
High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study.
Clin Infect Dis
; 61(5): 817-25, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25977266
4.
Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.
Clin Infect Dis
; 59(8): 1177-84, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24992955
5.
Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.
Clin Infect Dis
; 59(12): 1768-76, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25139963
6.
Current management of late onset neonatal bacterial sepsis in five European countries.
Eur J Pediatr
; 173(8): 997-1004, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24522326
7.
Presence of lamivudine or emtricitabine is associated with reduced emergence of nonnucleoside reverse transcriptase inhibitor mutations in an efavirenz-based intermittent antiretroviral treatment regimen.
Antimicrob Agents Chemother
; 56(3): 1655-7, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22203586
8.
Acceptability of an "on-demand" pre-exposure HIV prophylaxis trial among men who have sex with men living in France.
AIDS Care
; 24(4): 468-77, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22085083
9.
Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial.
Ann Intern Med
; 155(11): 733-41, 2011 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22147712
10.
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial.
J Infect Dis
; 204(1): 124-34, 2011 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21628666
11.
Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial.
Antimicrob Agents Chemother
; 55(7): 3613-5, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21576452
12.
Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial.
J Antimicrob Chemother
; 66(9): 2099-106, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21712241
13.
Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138).
HIV Clin Trials
; 11(5): 283-93, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21126958
14.
Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field.
Clin Trials
; 7(1): 19-35, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20156955
15.
Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial.
PLoS One
; 15(3): e0229380, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130261
16.
Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial.
Clin Infect Dis
; 49(8): 1259-67, 2009 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19757993
17.
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
J Antimicrob Chemother
; 64(1): 118-25, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19420019
18.
Resistance and virological response analyses in a three initial treatment strategy trial: a substudy of the INITIO trial.
HIV Clin Trials
; 10(6): 385-93, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-20133269
19.
The Task-force in Europe for Drug Development for the Young (TEDDY) Network of Excellence.
Paediatr Drugs
; 11(1): 18-21, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19127946
20.
HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.
Antivir Ther
; 13(4): 537-45, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18672532